Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2021 08:25 ET | Source: Exagen Inc.

Exagen Appoints Ana Hooker to Board of Directors

SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional...
June 18, 2021 08:29 ET | Source: Exagen Inc.

Exagen Elects Frank Stokes to Board of Directors

SAN DIEGO, June 18, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the company’s stockholders approved the election of...
May 24, 2021 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 41st Annual Growth...
May 11, 2021 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports First Quarter 2021 Results

Quarterly Records: AVISE® CTD Volumes, Ordering Healthcare Providers and Adopters SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing...
May 04, 2021 16:05 ET | Source: Exagen Inc.

Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests

SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, Allegheny Health Network (AHN) Research Institute and the AHN Autoimmunity...
April 27, 2021 16:05 ET | Source: Exagen Inc.

Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2021 after...
March 29, 2021 08:25 ET | Source: Exagen Inc.

Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases

SAN DIEGO, March 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
March 22, 2021 22:01 ET | Source: Exagen Inc.

Exagen Inc. Announces Pricing of Public Offering of Common Stock

SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of an underwritten public offering of...
March 22, 2021 16:05 ET | Source: Exagen Inc.

Exagen Inc. Announces Proposed Public Offering of Common Stock

SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it intends to offer and sell, subject to market and...
March 16, 2021 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...

Next Page keyboard_arrow_right